Evidence map›Paper›PMID 41852606›Full record

ArticleFrontiers in cardiovascular medicine2026

Outcomes in heart failure patients with third-degree heart block during COVID-19.

Benjamin Kash, Ethan Wahle, Eli Blaney, Saif Zurob, Amjad Kabach, Ali Bin Abdul Jabbar

Abstract read
In one paragraph

Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Benjamin KashCreighton University School of Medicine, Omaha, NE, United States.
Ethan WahleCreighton University School of Medicine, Omaha, NE, United States.
Eli BlaneyCreighton University School of Medicine, Omaha, NE, United States.
Saif ZurobCreighton University School of Medicine, Omaha, NE, United States.
Amjad KabachDepartment of Internal Medicine, Creighton University School of Medicine, Omaha, NE, United States.
Ali Bin Abdul JabbarDepartment of Internal Medicine, Creighton University School of Medicine, Omaha, NE, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Heart failure is a common sequela of third-degree heart block. This study examines trends in mortality and utilization of medical resources before and during the COVID-19 pandemic in patients with heart failure and third-degree heart block. We also seek to investigate outcomes for different patient demographics, hospital characteristics, and related medical comorbidities. Methods: Hospital admissions of adults with a primary diagnosis of heart failure and a history of third-degree heart block during the period between 2017 and 2022 were selected from the Healthcare Cost and Utilization Project National Inpatient Sample. The primary outcome was all-cause mortality; secondary outcomes were hospital length of stay and total hospital charges. Propensity matching was performed to account for differences between the two sample populations and reduce selection bias. Mortality was analyzed using logistic regression; the secondary outcomes were analyzed by using linear regression. Results: There were 22,900 prepandemic (2017-2019) hospitalizations of patients with heart failure and third-degree heart block and 37,530 hospitalizations during the pandemic (2020-2022). There was no associated difference in all-cause mortality ( Conclusion: There was no change in all-cause mortality length of stay or total charges of hospitalized patients with heart failure and a history of third-degree heart block during the COVID-19 pandemic as compared to before the pandemic. Certain comorbidities, however, were associated with higher mortality in this population.

Indexed as

COVID-19 pandemicheart failurein-hospital mortalitylength of staythird-degree heart blocktotal hospital charges

Identifiers

PMID41852606
PMCPMC12991969

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.